The role of Artificial Intelligence (AI) in drug discovery has been rapidly increasing in recent years, opening up new possibilities in this field. Against the backdrop of high failure rates in the pharmaceutical industry, several startup companies are investing all their capital in this technology, believing in the power of AI to develop new drugs.
Redaksiya reports that these companies are striving to accelerate the drug discovery process and create more effective drugs with the help of AI. They leverage AI's ability to analyze large volumes of data, identify potential drug candidates, and increase the success probability of clinical trials. This approach can be faster and cheaper compared to traditional drug discovery methods. AI is used to model molecular structures, predict drug mechanisms of action, and analyze complex data related to diseases.
Companies in this field are particularly focused on developing new drugs against cancer, Alzheimer's, and other complex diseases. Drug discovery with the help of AI also allows for reducing drug side effects and developing personalized treatment plans for patients. However, developments in this area are still in their early stages, and the full potential of AI in drug discovery has not yet been fully realized.
Consequently, the role of artificial intelligence in drug discovery is steadily increasing, and startup companies in this field are striving to revolutionize the pharmaceutical industry with the help of AI. This can open new horizons in the treatment of diseases, as well as make the drug discovery process more effective and faster.
Farid Alizade